n-3 polyunsaturated fatty acids and cardiovascular diseases

被引:102
|
作者
Nordoy, A
Marchioli, R
Arnesen, H
Videbæk, J
机构
[1] Univ Tromso, Dept Med, Tromso, Norway
[2] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, Italy
[3] Univ Hosp, Ulleval Hosp, Dept Cardiol, Oslo, Norway
[4] Heart Assoc, Dept Res, Copenhagen K, Denmark
关键词
D O I
10.1007/s11745-001-0695-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An expert round table discussion on the relationship between intake of n-3 polyunsaturated fatty acids (PUFA) mainly of marine sources and coronary heart disease at the 34th Annual Scientific Meeting of European Society for Clinical Investigation came to the following conclusions: 1. Consumption of 1-2 fish meals/wk is associated with reduced coronary heart disease (CHD) mortality. 2. Patients who have experienced myocardial infarction have decreased risk of total, cardiovascular, coronary, and sudden death by drug treatment with 1 g/d of ethylesters of n-3 PUFA, mainly as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The effect is present irrespective of high or low traditional fish intake or simultaneous intake of other drugs for secondary CHD prevention. n-3 PUFA may also be given as fatty fish or triglyceride concentrates. 3. Patients who have experienced coronary artery bypass surgery with venous grafts may reduce graft occlusion rates by administration of 4 g/d of n-3 PUFA. 4. Patients with moderate hypertension may reduce blood pressure by administration of 4 g/d of n-3 PUFA. 5. After heart transplantation, 4 g/d of n-3 PUFA may protect against development of hypertension. 6. Patients with dyslipidemia and or postprandial hyperlipemia may reduce their coronary risk profile by administration of 1-4 g/d of marine n-3 PUFA. The combination with statins seems to be a potent alternative in these patients. 7. There is growing evidence that daily intake of up to 1 energy% of nutrients from plant n-3 PUFA (alpha-linolenic acid) may decrease the risk for myocardial infarction and death in patients with CHD. This paper summarizes the conclusions of an expert panel on the relationship between n-3 PUFA and CHD. The objectives for the experts were to formulate scientifically sound conclusions on the effects of fish in the diet and the administration of marine n-3 PUFA, mainly eicosapentaen.oic acid (EPA, 20.5n-3) and docosahexaenoic acid (DHA, 22:6n-3), and eventually of plant n-3 PUFA, alpha-linolenic acid (ALA, 18:3n-3), on primary and secondary prevention of CHID. Fish in the diet should be considered as part of a healthy diet low in saturated fats for everybody, whereas additional administration of n-3 PUFA concentrates could be given to specific groups of patients. This workshop was organized on the basis of questions sent to the participants beforehand, on brief introductions by the participants, and finally on discussion and analysis by a group of -40 international scientists in the fields of nutrition, cardiology, epidemiology, lipidology, and thrombosis.
引用
收藏
页码:S127 / S129
页数:3
相关论文
共 50 条
  • [41] POLYUNSATURATED FATTY-ACIDS (N-3, N-6)
    NESTEL, PJ
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1987, 45 (05): : 1161 - 1167
  • [42] n-3 Polyunsaturated fatty acids in animal models with neuroinflammation
    Orr, Sarah K.
    Trepanier, Marc-Olivier
    Bazinet, Richard P.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2013, 88 (01): : 97 - 103
  • [43] n-3 Polyunsaturated fatty acids and their effect on cardiac mortality
    Sellmayer, A
    CLINICAL NUTRITION, 2002, 21 : 31 - 34
  • [44] N-3 polyunsaturated fatty acids and statins in heart failure
    Florkowski, Christopher
    Molyneux, Sarah
    George, Peter
    Lever, Michael
    Richards, Mark
    LANCET, 2009, 373 (9661): : 379 - 380
  • [45] N-3 polyunsaturated fatty acids and inflammation in the arterial wall
    Yaqoob, P
    Calder, PC
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2003, 8 (08) : 337 - 354
  • [46] Therapeutic potential of n-3 polyunsaturated fatty acids in disease
    Fetterman, James W., Jr.
    Zdanowicz, Martin M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (13) : 1169 - 1179
  • [47] Are all n-3 polyunsaturated fatty acids created equal?
    Anderson, Breanne M.
    Ma, David W. L.
    LIPIDS IN HEALTH AND DISEASE, 2009, 8
  • [48] Studies on the metabolic fate of n-3 polyunsaturated fatty acids
    Ferdinandusse, S
    Denis, S
    Dacremont, G
    Wanders, RA
    JOURNAL OF LIPID RESEARCH, 2003, 44 (10) : 1992 - 1997
  • [49] n-3 polyunsaturated fatty acids to heal the broken heart
    Grenon, Sophie Marlene
    Conte, Michael S.
    CLINICAL LIPIDOLOGY, 2013, 8 (05) : 497 - 500
  • [50] n-3 Polyunsaturated fatty acids and mast cell activation
    Wang, Xiaofeng
    Kulka, Marianna
    JOURNAL OF LEUKOCYTE BIOLOGY, 2015, 97 (05) : 859 - 871